RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis

Autor: Kruszewski, Adam M., Rao, Gautam, Tatomir, Alexandru, Hewes, Daniel, Tegla, Cosmin A., Cudrici, Cornelia D., Nguyen, Vingh, Royal, Walter, III, Bever, Christopher T., Jr, Rus, Violeta, Rus, Horea
Zdroj: In Experimental and Molecular Pathology December 2015 99(3):498-505
Databáze: ScienceDirect
Externí odkaz: